Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12352816 | 0.89 | NPSR1 (0.36) | NPSR1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL18649680 | 0.85 | NPSR1 (0.36) | NPSR1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL18898568 | 0.85 | NPSR1 (0.40) | NPSR1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL18785335 | 0.85 | NPSR1 (0.39) | NPSR1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL23519372 | 0.84 | NPSR1 (0.32) | NPSR1 | |
| SCHEMBL26063484 | 0.84 | NPSR1 (0.37) | NPSR1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL18785950 | 0.83 | NPSR1 (0.38) | NPSR1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL786552 | 0.83 | NPSR1 (0.39) | NPSR1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL786286 | 0.82 | NPSR1 (0.40) | NPSR1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL10135332 | 0.82 | NPSR1 (0.36) | NPSR1MEN1KMT2AL3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210179554-A1 | ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210179554-A1 | ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SLC6A5, LIFR, SLC6A9 | NPSR1 3697/4885MEN1 3280/4885KMT2A 2267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.